Sanofi (ETR:SNW)
80.62
+1.40 (1.77%)
Feb 2, 2026, 5:27 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
€563,672
Profits / Employee
€94,271
Market Cap
95.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Fresenius Medical Care AG | 109,916 |
| Bayer Aktiengesellschaft | 88,502 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 62,346 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,878 |
| Carl Zeiss Meditec AG | 5,784 |
Sanofi News
- 3 days ago - Sanofi (SNY) Gains Positive EU Nod for Rezurock Approval - GuruFocus
- 3 days ago - Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News - The Motley Fool
- 3 days ago - Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation - Seeking Alpha
- 3 days ago - Sanofi Announces Positive CHMP Opinion For Rezurock In EU - Finanz Nachrichten
- 3 days ago - Sanofi (SNY) Gains EU Panel Support for Rezurock Approval - GuruFocus
- 3 days ago - Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds - Seeking Alpha
- 3 days ago - Press Release: Sanofi's Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease - GlobeNewsWire
- 3 days ago - Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... - GuruFocus